Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$120K Buy
7,397
+297
+4% +$3.51K ﹤0.01% 1266
2025
Q4
$26.4K Hold
7,100
﹤0.01% 1985
2025
Q3
$15.5K Sell
7,100
-779
-10% -$1.24K ﹤0.01% 2224
2025
Q2
$10K Buy
7,879
+5,139
+188% +$6.88K ﹤0.01% 2350
2025
Q1
$3.75K Buy
+2,740
New +$4.7K ﹤0.01% 2699
2024
Q2
Sell
-1,551
Closed -$3.19K 3161
2024
Q1
$3.19K Sell
1,551
-1,117
-42% -$2.23K ﹤0.01% 2673
2023
Q4
$5.68K Sell
2,668
-2,604
-49% -$5.49K ﹤0.01% 2462
2023
Q3
$10.4K Buy
5,272
+2,689
+104% +$6.89K ﹤0.01% 2198
2023
Q2
$7.13K Sell
2,583
-869
-25% -$2.48K ﹤0.01% 2384
2023
Q1
$10.4K Buy
3,452
+3,312
+2,366% +$12K ﹤0.01% 2193
2022
Q4
$603 Buy
+140
New +$949 ﹤0.01% 3075

Other funds holding ERAS

SignatureFD's ERAS Position: Q1 2026 in Review

SignatureFD increased its Erasca (ERAS) stake by 4.2% in Q1 2026, buying an estimated $3.51K and bringing the position to 7,397 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

SignatureFD first reported a position in ERAS in Q4 2022 and has held it in 11 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • SignatureFD held 7,397 shares of Erasca worth $120K as of Q1 2026.
  • SignatureFD bought 297 Erasca shares in Q1 2026, an estimated $3.51K.
  • Erasca made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #1266 holding.
  • SignatureFD first reported a position in Erasca in Q4 2022 and has held it in 11 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.